Associated Papers
Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer.
McCann K et al.
Journal for Immunotherapy of Cancer, 2022
35361728 (PubMed )
Supplement: jitc-2021-003821supp002.pdf
A Mutation in ZNF143 as a Novel Candidate Gene for Endothelial Corneal Dystrophy.
Kim Y et al.
Journal of Clinical Medicine, 2019
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer.
Iyer P et al.
International Journal of Cancer, 2019
30304546 (PubMed )
Supplement: IJC-144-2008-s001.pdf
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors.
Ahlborn LB et al.
Oncotarget, 2018
30220966 (PubMed )
Supplement: oncotarget-09-32570-s003.xlsx › Sheet1
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
Raaijmakers MI et al.
Oncotarget, 2016
27791198 (PubMed )
Supplement: oncotarget-07-77163-s002.xlsx › Patient_3_late_met_1
Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts.
Kemper K et al.
Embo Molecular Medicine, 2015
26105199 (PubMed )
Supplement: emmm0007-1104-sd1.pdf
Select a paper to view details